D'ARRIGO, GIULIA

D'ARRIGO, GIULIA  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autore(i) File
Binding of androgen-and estrogen-like flavonoids to their cognate (Non)nuclear receptors: A comparison by computational prediction 2021 D'arrigo G.; Gianquinto E.; Rossetti G.; Cruciani G.; Lorenzetti S.; Spyrakis F.
Can we exploit β-lactamases intrinsic dynamics for designing more effective inhibitors? 2020 Gianquinto E.; Tondi D.; D'arrigo G.; Lazzarato L.; Spyrakis F.
Cooperativity as quantification and optimization paradigm for nuclear receptor modulators 2022 de Vink, Pim J; Koops, Auke A; D'Arrigo, Giulia; Cruciani, Gabriele; Spyrakis, Francesca; Brunsveld, Luc
Discovering New Casein Kinase 1d Inhibitors with an Innovative Molecular Dynamics Enabled Virtual Screening Workflow 2019 Sciabola, Simone; Benedetti, Paolo; D’Arrigo, Giulia; Torella, Rubben; Baroni, Massimo; Cruciani, Gabriele; Spyrakis, Francesca
Exploring Ligand Binding Domain Dynamics in the NRs Superfamily 2022 D'Arrigo, Giulia; Autiero, Ida; Gianquinto, Eleonora; Siragusa, Lydia; Baroni, Massimo; Cruciani, Gabriele; Spyrakis, Francesca
First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase 2019 Spyrakis, Francesca; Bellio, Pierangelo; Quotadamo, Antonio; Linciano, Pasquale; Benedetti, Paolo; D'Arrigo, Giulia; Baroni, Massimo; Cendron, Laura; Celenza, Giuseppe; Tondi, Donatella
Multiple catalytic activities of human 17β-hydroxysteroid dehydrogenase type 7 respond differently to inhibitors. 2020 Ferrante T, Adinolfi S, D'Arrigo G, Poirier D, Daga M, Lolli ML, Balliano G, Spyrakis F, Oliaro-Bosso S.
Strigolactone analogs are promising antiviral agents against Herpesviruses 2021 Matteo Biolatti, Marco Blangetti, Giulia D’Arrigo, Francesca Spyrakis, Paola Cappello, Camilla Albano, Sergio Fernando Castillo Pacheco, Santo Landolfo, Cristina Prandi, Marco De Andrea, Valentina Dell’Oste
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 2020 CAMILLA ALBANO, MATTEO BIOLATTI, MARCO BLANGETTI, GIULIA D’ARRIGO, FRANCESCA SPYRAKIS, PAOLA CAPPELLO, PAOLO RAVANINI, SELINA PASQUERO, FRANCESCA GUGLIESI, SERGIO F. CASTILLO PACHECO, SANTO LANDOLFO, MARCO DE ANDREA, CRISTINA PRANDI, VALENTINA DELL’OSTE
Strigolactone analogs are promising antiviral agents for the treatment of human cytomegalovirus infection 2021 MATTEO BIOLATTI , MARCO BLANGETTI , GIULIA D’ARRIGO, FRANCESCA SPYRAKIS, PAOLA CAPPELLO, CAMILLA ALBANO, SERGIO FERNANDO CASTILLO PACHECO, LINDA TRIFIRO’ , PAOLO RAVANINI , SANTO LANDOLFO, MARCO DE ANDREA, CRISTINA PRANDI , VALENTINA DELL’OSTE
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 2020 Matteo Biolatti, Marco Blangetti, Giulia D’Arrigo, Francesca Spyrakis, Paola Cappello, Camilla Albano, Paolo Ravanini, Santo Landolfo, Marco De Andrea, Cristina Prandi, Valentina Dell’Oste
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 2019 SELINA PASQUERO, GLORIA GRIFFANTE, FRANCESCA GUGLIESI, VALENTINA DELL’OSTE, MATTEO BIOLATTI, GANNA GALITSKA, MARCO BLANGETTI, CRISTINA PRANDI, PAOLA CAPPELLO, FRANCESCA SPYRAKIS, GIULIA D’ARRIGO, MARCO DE ANDREA, SANTO LANDOLFO
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 2022 Camilla Albano, Matteo Biolatti, Marco Blangetti, Greta Bajetto, Davide Arnodo, Melissa Baggeri, Matteo Bersani, Giulia D’Arrigo, Marco De Andrea, Francesca Gugliesi, Selina Pasquero, Ivan Visentin, Cristina Prandi, Francesca Spyrakis, Fabio Magurano, Valentina Dell’Oste